X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/redhill-biopharma-announces-full-year-2023-results-and-operational-highlights-302110455.html
https://www.prnewswire.com/news-releases/redhill-biopharma-announces-1-25-million-registered-direct-offering-at-a-premium-to-market-price-302105607.html
https://www.prnewswire.com/news-releases/redhill-announces-new-uspto-patent-covering-talicia-through-2034-302085225.html
https://www.prnewswire.com/news-releases/redhills-opaganib-selected-for-evaluation-by-barda-and-nih-countermeasures-programs-302079686.html
https://www.prnewswire.com/news-releases/redhills-opaganib-protects-against-radiation-induced-lung-inflammation-and-fibrosis--new-publication-302065891.html
https://www.prnewswire.com/news-releases/redhill-biopharma-announces-closing-of-8-million-registered-direct-offering-302045836.html
https://www.prnewswire.com/news-releases/redhill-biopharma-announces-8-million-registered-direct-offering-302044755.html
https://www.prnewswire.com/news-releases/redhill-announces-new-uspto-patent-grant-for-talicia-for-h-pylori-treatment-through-2042-302044556.html
https://www.prnewswire.com/news-releases/redhill-and-us-army-announce-opaganib-and-rhb-107-combinations-with-remdesivir-show-distinct-synergistic-effect-against-ebola-302020104.html
https://www.prnewswire.com/news-releases/redhill-biopharma-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302012391.html
Market Place
Share 
